1. Home
  2. OLPX vs RGNX Comparison

OLPX vs RGNX Comparison

Compare OLPX & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olaplex Holdings Inc.

OLPX

Olaplex Holdings Inc.

HOLD

Current Price

$1.25

Market Cap

680.9M

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$13.16

Market Cap

661.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLPX
RGNX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.9M
661.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
OLPX
RGNX
Price
$1.25
$13.16
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$1.81
$30.29
AVG Volume (30 Days)
1.1M
616.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$418,582,000.00
$161,318,000.00
Revenue This Year
$2.15
$132.80
Revenue Next Year
$2.31
$48.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
91.30
52 Week Low
$0.99
$5.04
52 Week High
$2.28
$13.93

Technical Indicators

Market Signals
Indicator
OLPX
RGNX
Relative Strength Index (RSI) 66.34 59.81
Support Level $1.10 $12.05
Resistance Level $1.20 $13.77
Average True Range (ATR) 0.06 0.80
MACD 0.02 0.10
Stochastic Oscillator 94.60 77.74

Price Performance

Historical Comparison
OLPX
RGNX

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: